
Currently, cancer vaccine therapy for melanoma has a zzso zzso On the one hand, advances have been aimed at improving the effectiveness of melanoma vaccines based on a greater understanding of melanoma tumor cell zzso On the other hand, there is increasing evidence that the immune system, our defense against tumors, also inadvertently plays a supportive role in promoting the development and progression of zzso zzso two opposing forces zzso in the zzso dictate patients' responses to zzso tumor cell biology and the status of the immune zzso Recent developments in our understanding of both of these aspects have provided new leads and insights for novel ways to improve vaccine design and add to the melanoma vaccine zzso As the focus of zzso shifts its aim towards the tumor zzso we are now developing the ability to program the immune responses raised by vaccination against zzso The aim here is to prevent zzso and regulatory zzso immune suppression as well as to counteract zzso factors capable of suppressing immune zzso A redirected strategy for vaccine zzso is proposed based on our greater understanding of tumor zzso Using a combination therapy of zzso melanoma vaccines together with zzso for overcoming the zzso forces will allow us to activate protective immunity against zzso Other cancer vaccines zzso colon or zzso are already offering reasons for hope and expectation that vaccine zzso will also produce successful outcomes for patients with zzso 

